dcsimg
GLOBAL OFFERING

 

ALPHAMAB ONCOLOGY (09966)
 
 
COVER
IMPORTANT
EXPECTED TIMETABLE
CONTENTS
SUMMARY
DEFINITIONS
GLOSSARY OF TECHNICAL TERMS
FORWARD-LOOKING STATEMENTS
RISK FACTORS
WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTIONS FROM COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE
INFORMATION ABOUT THIS PROSPECTUS AND THE GLOBAL OFFERING
DIRECTORS AND PARTIES INVOLVED IN THE GLOBAL OFFERING
CORPORATE INFORMATION
INDUSTRY OVERVIEW
REGULATIONS
HISTORY, REORGANIZATION AND CORPORATE STRUCTURE
BUSINESS
DIRECTORS AND SENIOR MANAGEMENT
RELATIONSHIP WITH CONTROLLING SHAREHOLDERS
CONNECTED TRANSACTIONS
SUBSTANTIAL SHAREHOLDERS
SHARE CAPITAL
FINANCIAL INFORMATION
CORNERSTONE INVESTORS
FUTURE PLANS AND USE OF PROCEEDS
UNDERWRITING
STRUCTURE OF THE GLOBAL OFFERING
HOW TO APPLY FOR HONG KONG OFFER SHARES
APPENDIX I - ACCOUNTANTS' REPORT
APPENDIX II - UNAUDITED PRO FORMA FINANCIAL INFORMATION
APPENDIX III - PROPERTY VALUATION REPORT
APPENDIX IV - SUMMARY OF THE CONSTITUTION OF THE COMPANY AND CAYMAN ISLANDS COMPANY LAW
APPENDIX V - STATUTORY AND GENERAL INFORMATION
APPENDIX VI - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES AND AVAILABLE FOR INSPECTION
BACK COVER